Financials
- Market Capitalization 43.12 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.59
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4293 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.14 USD | +1.90% | +1.90% | +2.39% | -46.23% | 45.02 M USD | ||
| 4301 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.16 USD | -0.85% | -5.69% | -3.33% | -19.44% | 43.82 M USD | ||
| 4323 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.79 USD | -3.24% | -10.05% | -9.60% | -81.43% | 40.60 M USD | ||
| 4331 | CRVO CervoMed Inc. - Common Stock | 2.64 USD | +2.72% | -0.38% | -1.86% | -75.42% | 39.91 M USD |